I am a doctor - it’s a profession that may be considered a special mission, a devotion. It calls for involvement, respect and willingness to help all other people.

Qualification

MBBS, MDRT

Language

English, આ, हिंदी, मराठी, తెలుగు

Registration No

11456

Experience

30 years +


Location

Apollo Health City Jubilee Hills

Apollo Health City, Road No 72, Opp. Bharatiya Vidya Bhavan School, Film Nagar, Jubilee Hills, Hyderabad, Telangana 500033
Timing SUN- SAT (09:00 AM-05:30 PM)
Get Direction

Work Experience

    • June 2003 till Date:Worked as Chief oncologist at Kamineni Hospitals Hyderabad, Telangana
    • 1992-2003:Consultant oncologist at Medwin Hospitals, Hyderabad & visiting consultant at kamineni hospitals, Hyderabad
    • 1988-1991:Post Graduation Programme MDRT at MNJ Cancer Hospitals under Osmania Medical College, NTR Health University including 6 months training at Tata Memorial Hospitals, Mumbai 
    • 1985-1988:Senior Resident at Azam Hospitals, Hyderabad
    • 1984-1985:Osmania General Hospitals as Rotatory Internship.
    Clinical Trial Experience:
    • Co investigator in A single blind randomized phase III trial of MTA+Inj. Cisplatin vs Inj. Cisplatin in patients with malignant pleural Mesothelioma-Protocol H3E MC JMCH (a) (ELLi Lilly).
     
     

Awards and Achievements

    • Frank Neal Fellowship from Associated of Radiation Oncologists of India in 1992.
    • Visited New York, USA to work with Dr.Dattatreyudu Nori in 1996 at Queens Hospitals.
    • Held the post of Treasurer in Association of Radiation Oncologists of India-AP Chapter (2Years)
    • Held the Post of President in Association of Radiation Oncologists of India -AP Chapter.
    • Member Secretary for institutional ethical committe from 2013 to 2019.  
     

Research and Publications

  • Papers Published:
    • THESIS: Role of Radiotherapy in Oncological Emergencies-Submitted to NTR Health University in 1991.
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah,Dr.R.K.Sur -Metastatic skull Secondaries from Ddeno carcinoma of the oesophagus.J.Cli.Rt & Onc, 1993, 8, 46-9.
    • 3. Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur-Early Carcinoma of Pelvis treatment with Radiotherapy, A Priliminary Report. Med.Phy.Bull, 1993.
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur-Experience with Interferons at Medwin Cancer Hospitals. Ind. J. Hema.1993.
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur-A Treatment of Testicular Tumors-A Review.Med Cli.J, 1993.
    • Dr.Babaiah,Dr.Sudharsan,Dr.Ashwin.M.Shah,Dr.R.K.Sur-A Treatment of Oesophageal Cancers with Intra Luminal  Radiotherapy.Med.Cli.J,1993. 
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur-Ectopia Vesica - complicated by Adeno Squamous cell Carcinoma - case Report.J.CI.Onc,1993.  
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur-Juvenile CML in 8 Yrs old patient- submitted for Publication.
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.R.K.Sur- Human Placental extract in the treatment of Mucositis induced by Radiotherapy -Presented at AROI Conference, Jamshedpur.
    • Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.Ravi.K - RT& concurrent Chemotherapy with cisplatin (Dy/Wly) one in locally advanced Head & Neck Cancers - Presented at 16th AROI Conference, Trivandraum.
    • 11. Dr.Babaiah, Dr.Sudharsan, Dr.Ashwin.M.Shah, Dr.Ravi.K - Use of Radioactive Phosphorous -32 in the treatment of skeletal Metastasis. Presented at AROI Conference, Ludiana, 1995.
    • V.Bhavani ,G.Sujatha,M. Sireesha, G.S.N. Raju, Dr.Ashwin.M.Shah,Pari Ramesh, Y.R. Ahuja &Q. Hasan - Association of Progins with Breast Cancer.
    • Mina Darooei, Subhadra Poornima,Bibi Umae Salma, Gayatri R Iyer, Akhilesh N Pujar, Srirambhatla Annapurna , Dr.Ashwin M Shah, Srinivas Maddali and Q. Hasan - “Pedigree and BRCA Gene Analysis in Breast Cancer Patients to identify Hereditary Breast and Ovarian Cancer Syndrome to Prevent Mortality of Disease in Indian Population”. 2017.
    • Dr. Arpitha S Rao , Dr. Ashwin M Shah - “Analysis of Relationship between Emotional intelligence and Quality of Life in Oncology Patients”. 2018.
    • Darooei M, Khan F, Rehan M, Zubeda S, Jeyashanker E, Annapurna S, Shah A, Maddali S, Hasan Q. “MED12 Somatic Muations Encompassing Exon2 Associated with Benign breast Fibroadenomas and not Breast carcinoma in indian women” Journal: Journal of Cellular Biochemistry 2018
    • Kamireddy AP, Shah AM, Mereddy SR, Deshpande AK, Hasan Q. BRAF V600E VARIANT IDENTIFIED AS TARGETTABLE SOMATIC VARIANT PICKED UP BY NEXT GENERATION SEQUENCING IN THYROID TISSUE SAMPLES FROM SOUTH INDIA. Journal of advanced Scientific Research. 2020 Oct 2;11:302-05.
    • Kamireddy AP, Maddali S, Shah AM, Sai ram C, Hasan Q. Mutation panel testing for Targeted Therapy in Somatic Thyroid Tissues By next Generation Sequencing (submitted)  
     
Timing SUN- SAT (09:00 AM-05:30 PM)
Book Appointment
Need Help? 1860 500 1066